Latacomp Teva Sweden (Timolol Maleate, Latanoprost)

Timolol maleate is a non‑selective beta‑adrenergic blocker. By blocking beta receptors in the ciliary body, it reduces the production of aqueous humor, which contributes to a decrease in intra‑ocular pressure.

The dosing regimen for Latacomp is determined by the prescribing eye‑care professional. Typically, one drop is instilled in the affected eye(s) once daily, but the exact frequency and duration are individualized based on the patient’s response and clinical judgment.

The safety of Latacomp in pregnancy and lactation has not been fully established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare provider.

To order Latacomp, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Latacomp combines two mechanisms—beta‑blockade and prostaglandin‑mediated outflow enhancement—offering a broader pressure‑lowering effect than single‑agent drops. This can simplify therapy for patients who need both actions, potentially improving adherence compared with using two separate medications.

Latacomp should be stored at room temperature, below 25 °C. Keep the bottle in its original packaging, protect it from light, and avoid exposure to moisture. Do not freeze the solution.

Latacomp is applied as an eye drop. The patient should wash their hands, tilt the head back, pull down the lower eyelid to create a pocket, and instill one drop into the conjunctival sac. Close the eye gently for a few seconds and avoid blinking excessively.

Serious risks include severe allergic reactions, significant eye pain or inflammation, permanent darkening of the iris, and systemic effects such as bradycardia or worsening of asthma. Patients should seek immediate medical attention if they experience any of these symptoms.

Latacomp is contraindicated in patients with known hypersensitivity to timolol, latanoprost, or any excipients in the formulation. It should also be avoided in individuals with severe asthma, chronic obstructive pulmonary disease, or certain cardiac conduction disorders unless specifically advised by a physician.